NCT04105010 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 120
- group Id
- BG004
- value
- 171
- units
- Participants
- groups
- description
- Group A: Open label AZD4205 at 150 mg, once daily (Phase 1) AZD4205: AZD4205 will be administered orally as capsules. AZD4205 treatment will be continued until disease progression or intolerant adverse reactions
- id
- BG000
- title
- AZD4205 Group A
- description
- Group B: Open label AZD4205 at 250 mg, once daily (Phase 1) AZD4205: AZD4205 will be administered orally as capsules. AZD4205 treatment will be continued until disease progression or intolerant adverse reactions
- id
- BG001
- title
- AZD4205 Group B
- description
- Group C: Open label AZD4205 at 150 mg, once daily (Phase 1) AZD4205: AZD4205 will be administered orally as capsules. AZD4205 treatment will be continued until disease progression or intolerant adverse reactions
- id
- BG002
- title
- AZD4205 Group C
- description
- Group D: Open label AZD4205 at the 150 mg (RP2D), once daily (Phase 2) AZD4205: AZD4205 will be administered orally as capsules. AZD4205 treatment will be continued until disease progression or intolerant adverse reactions
- id
- BG003
- title
- AZD4205 Group D
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 33
- upper Limit
- 78
- value
- 62.5
- group Id
- BG001
- lower Limit
- 29
- upper Limit
- 79
- value
- 61.5
- group Id
- BG002
- lower Limit
- 39
- upper Limit
- 74
- value
- 55.0
- group Id
- BG003
- lower Limit
- 20
- upper Limit
- 79
- value
- 58.0
- group Id
- BG004
- lower Limit
- 20
- upper Limit
- 79
- value
- 58.0
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 44
- group Id
- BG004
- value
- 61
- title
- Female
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 76
- group Id
- BG004
- value
- 110
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 100
- group Id
- BG004
- value
- 151
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 4
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 14
- group Id
- BG004
- value
- 14
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 2
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- population Description
- Safety Analysis Set (all patients treated with at least one dose of AZD4205)
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 120
- group Id
- BG004
- value
- 171
- units
- Participants
- groups
- description
- Group A: Open label AZD4205 at 150 mg, once daily (Phase 1) AZD4205: AZD4205 will be administered orally as capsules. AZD4205 treatment will be continued until disease progression or intolerant adverse reactions
- id
- BG000
- title
- AZD4205 Group A
- description
- Group B: Open label AZD4205 at 250 mg, once daily (Phase 1) AZD4205: AZD4205 will be administered orally as capsules. AZD4205 treatment will be continued until disease progression or intolerant adverse reactions
- id
- BG001
- title
- AZD4205 Group B
- description
- Group C: Open label AZD4205 at 150 mg, once daily (Phase 1) AZD4205: AZD4205 will be administered orally as capsules. AZD4205 treatment will be continued until disease progression or intolerant adverse reactions
- id
- BG002
- title
- AZD4205 Group C
- description
- Group D: Open label AZD4205 at the 150 mg (RP2D), once daily (Phase 2) AZD4205: AZD4205 will be administered orally as capsules. AZD4205 treatment will be continued until disease progression or intolerant adverse reactions
- id
- BG003
- title
- AZD4205 Group D
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 33
- upper Limit
- 78
- value
- 62.5
- group Id
- BG001
- lower Limit
- 29
- upper Limit
- 79
- value
- 61.5
- group Id
- BG002
- lower Limit
- 39
- upper Limit
- 74
- value
- 55.0
- group Id
- BG003
- lower Limit
- 20
- upper Limit
- 79
- value
- 58.0
- group Id
- BG004
- lower Limit
- 20
- upper Limit
- 79
- value
- 58.0
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 44
- group Id
- BG004
- value
- 61
- title
- Female
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 76
- group Id
- BG004
- value
- 110
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 100
- group Id
- BG004
- value
- 151
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 4
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 14
- group Id
- BG004
- value
- 14
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 2
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- population Description
- Safety Analysis Set (all patients treated with at least one dose of AZD4205)
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle